| Catalog Number |
305220 |
| Medical Device Problem Code |
Device Markings/Labelling Problem (2911)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
11/08/2023
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
It was reported that the bs syringe oral 3ml clear contained mixed product/lots.The following information was provided by the initial reporter: po number, whs, item number, ordered quantity, discrepancy quantity, uom, reason, expiration date, lot number, warehouse, comments, supplier comments.(b)(4), il1, 58305220, (b)(4), 400, ea concealed damage, different item inside case, item inside 58305219.Addition information provided on 23jan2024: "item 305220 was received in full (1 case) once the warehouse opened this up, they realized inside the case was actually item 305219.The warehouse stated that they had 400 each there were incorrect and those were disposed of after no response.".
|
| |
|
Additional Manufacturer Narrative
|
|
B.3.The date received by manufacturer has been used for this field.E.1.Address was not located and il was used.No photos or physical samples of the bs syringe oral 3ml clear product code # 305220, with the reported issue of ¿mixed product / lots ¿, were available for investigation.Product undergoes inspections throughout the manufacturing process according to procedure.As the lot involved in this incident is unknown, a device history review cannot be performed.Based on the available information we are not able to identify a root cause at this time.Complaints received for this device and reported condition will continue to be tracked and trended.Our quality team regularly reviews the collected data for identification of emerging trends.H3 other text : see narrative below.
|
| |
|
Additional Manufacturer Narrative
|
|
Pr 9249460 follow-up report for correction.The date received from manufacturer was incorrect in the initial mdr.Customer provided confirmation on 22jan2024 that the complaint was the result of "mixed product/lots".
|
| |
|
Event or Problem Description
|
|
No additional information provided.
|
| |
|
Additional Manufacturer Narrative
|
|
Becton dickinson and company's (bd) medication delivery solutions (mds) business unit will discontinue malfunction mdr reporting for certain device failures that have not caused or contributed to deaths or serious injuries in the past two years, and where the likelihood of a death or serious injury as a result of these malfunctions is remote.This decision follows fda guidelines (medical device reporting for manufacturers guidance for industry and food and drug administration staff issued nov 8, 2016, reference section 2.15).Bd notified fda of this decision on mar 3, 2025.Fda has reviewed and responded to bd¿s notification (reference fda document # (b)(4)) on march 7, 2025.This documentation is available in bd document management system (sap) as (b)(4).This supplemental mdr is being filed to document that the below device failure will no longer be considered a reportable malfunction mdr for the product family below: product family: enteral/oral syringes.Device failure: mixed product / lots.
|
| |
|
Event or Problem Description
|
|
No additional information.
|
| |
|
Search Alerts/Recalls
|